Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
anisodamine (1 trial)
Shock (Phase 2)
Shock, Septic (Phase 2)
Trials (1 total)
Trial APIs (1 total)